Impact of Age and Geriatric Co-morbidities on Lymphocyte Phenotype in Patients 70 Years of Age and Older

NCT04772092•Centre Hospitalier Universitaire Dijon

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Geriatrics Immunosenescence

Interventions

Blood samples

Data collection

Key Dates

Start Date

November 1, 2021

Primary Completion Date

November 1, 2021

Completion Date

November 1, 2021

Last Updated

September 8, 2022

Sponsors

Lead Sponsor

Centre Hospitalier Universitaire Dijon

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 8, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions